StemCell Therapy

Telehealth provider Teladoc Health is teaming up with The Ohio State University Wexner Medical Center to improve remote disease management for people with Type 2 diabetes.

Starting July 1, Wexner patients can enroll in Teladoc's Livongo for Diabetes Program, a patient-centric customized wellness program designed to improve hemoglobin A1c and other metabolic markers that reduce diabetes complications and ultimately reducing the use of healthcare resources.

The Livongo program focuses on sustainable behavioral changes that improve glycemic and HbA1c levels for patients. The program relies on real-time feedback, live coaching, curated educational content, health nudges, and five-day mini challenges for patients. The system eases data sharing with patients' physicians, allowing them to monitor their patients' progress.

Livongo patients will get a cellular-connected blood glucose meter, unlimited test strips, 24/7 interventional support, and ongoing access to Teladoc clinicians.

"With the prevalence of diabetes growing nationwide and in Ohio, patients are faced with ever-increasing challenges to manage this disease," Hal Paz, MD, executive vice president and chancellor for Health Affairs at The Ohio State University and CEO of the Ohio State Wexner Medical Center, said in a media release.

"This partnership with Teladoc Health's Livongo disease management and chronic care unit is a complementary platform to deliver high quality care to our patients living with diabetes while advancing our commitment to digital health and innovation," Paz said.

John Commins is a content specialist and online news editor for HealthLeaders, a Simplify Compliance brand.

See more here:
Teladoc, OSU Wexner, Tag-team on Diabetes Care Initiative - HealthLeaders Media

This entry was posted on June 24, 2021 at 1:53 am and is filed under Diabetes. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |